Hutch News

Kuni Foundation awards $7M to drive adult oncology research forward

Kuni Foundation awards $7M to drive adult oncology research forward

Vancouver, Washington-based foundation supports innovative early-stage research on new potential therapies
Hutch NewsJune 30, 2025
TakePART-NW, an ambitious new precision oncology research program, launches at Fred Hutch

TakePART-NW, an ambitious new precision oncology research program, launches at Fred Hutch

Patients who opt in may help solve the mysteries of cancer and other diseases
Hutch NewsJune 13, 2025
Fred Hutch expands its research capacity in South Lake Union

Fred Hutch expands its research capacity in South Lake Union

Three new buildings will boost recruitment and strengthen science
Hutch NewsOctober 07, 2024
A quarter century of lifesaving discoveries in prostate cancer

A quarter century of lifesaving discoveries in prostate cancer

Pacific Northwest Prostate Cancer SPORE insights have transformed patient care and understanding of prostate cancer biology, supported drug discovery worldwide
Hutch NewsAugust 12, 2024
Fred Hutch launches rare cancer research effort

Fred Hutch launches rare cancer research effort

New TRACER initiative aims to accelerate advances through multidisciplinary collaboration and innovative approaches
Hutch NewsFebruary 09, 2024
Does prostate cancer have a goldilocks mentality when it comes to androgens?

Does prostate cancer have a goldilocks mentality when it comes to androgens?

From the Nelson lab, Human Biology and Clinical Research Divisions
Science SpotlightAugust 21, 2023
Classifying prostate cancer subtypes from liquid biopsies

Classifying prostate cancer subtypes from liquid biopsies

From the Ha and Nelson labs, Human Biology Division
Science SpotlightApril 17, 2023
New computational tools widen horizons for liquid biopsies

New computational tools widen horizons for liquid biopsies

Methods allow scientists to use gene regulation patterns to detect cancer subtype in cell-free DNA
Hutch NewsJanuary 12, 2023
Tracking prostate cancer dynamics

Tracking prostate cancer dynamics

Single-cell study brings prostate tumors into focus and highlights potential treatment target: cancer complexity
Hutch NewsDecember 13, 2022
Award will fund research into new metastatic prostate cancer therapies

Award will fund research into new metastatic prostate cancer therapies

Physician-scientist Dr. John Lee and his team will use $750K Kleberg Foundation grant to pursue new treatments, including immunotherapy
Hutch NewsOctober 21, 2022
“Why doesn’t cancer metastasize to your muscles?”

“Why doesn’t cancer metastasize to your muscles?”

From the Ghajar Lab, Breast & Ovary Cancer Program, Cancer Consortium
Science SpotlightMay 16, 2022
Good and surprising news finds germline mutations are rare in low-risk prostate cancer

Good and surprising news finds germline mutations are rare in low-risk prostate cancer

From the Nelson Lab, part of the Human Biology and Public Health Sciences Divisions
Science SpotlightMay 16, 2022
Genomic attributes predict cancer treatment responsiveness

Genomic attributes predict cancer treatment responsiveness

From the Nelson Lab, Human Biology & Clinical Research Divisions
Science SpotlightFebruary 21, 2022
Using AI to identify potential COVID-19, cancer therapies

Using AI to identify potential COVID-19, cancer therapies

Early findings show current drugs might be repurposed to calm COVID-19’s cytokine storms, treat metastatic prostate cancer
Hutch NewsSeptember 30, 2021
Exercise video series for prostate cancer patients launches

Exercise video series for prostate cancer patients launches

A new resource designed to help improve patients’ overall quality of life
Hutch NewsAugust 24, 2020
Black men with early-stage prostate cancer can do active surveillance

Black men with early-stage prostate cancer can do active surveillance

New study using Canary PASS data shows African American men with low-risk disease can delay radical treatment just like white men
Hutch NewsNovember 27, 2019